Details of the Drug Reposition

General Information of This Drug (ID: DM7YFW5)

Drug Name
OPB-111077   DM7YFW5
Drug Type
Small interfering RNA

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 1 [1]
Haematological malignancy DISCDP7W 2B33.Y Phase 1 [1]
Hepatocellular carcinoma DIS0J828 2C12.02 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02250170) Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor. U.S. National Institutes of Health.